These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7749763)

  • 1. Long-term granulocyte-macrophage colony-stimulating factor and immunosuppression in the treatment of acquired severe aplastic anemia.
    Hord JD; Gay JC; Whitlock JA; Janco RL; Edwards JR; Greer JP; Lukens JN
    J Pediatr Hematol Oncol; 1995 May; 17(2):140-4. PubMed ID: 7749763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunosuppressive therapy using antithymocyte globulin and cyclosporin A with or without human granulocyte colony-stimulating factor in children with acquired severe aplastic anemia].
    Liu X; Zou Y; Wang S; Zhang L; Yang W; Zhang J; Liu F; Liu T; Chen X; Ruan M; Zhou J; Cai X; Qi B; Chang L; An W; Guo Y; Chen Y; Zhu X
    Zhonghua Er Ke Za Zhi; 2014 Feb; 52(2):84-9. PubMed ID: 24739716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocyte-macrophage colony stimulating factor and immunosuppression in the treatment of pediatric acquired severe aplastic anemia.
    Jeng MR; Naidu PE; Rieman MD; Rodriguez-Galindo C; Nottage KA; Thornton DT; Li CS; Wiang WC
    Pediatr Blood Cancer; 2005 Aug; 45(2):170-5. PubMed ID: 15593082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study.
    Locasciulli A; Bruno B; Rambaldi A; Saracco P; Dufour C; Finelli C; Sica S; Varotto S; Arcese W; Locatelli F; Soligo D; Bacigalupo A;
    Haematologica; 2004 Sep; 89(9):1054-61. PubMed ID: 15377466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow transplantation in pediatric patients with severe aplastic anemia: cyclophosphamide and anti-thymocyte globulin conditioning followed by recombinant human granulocyte-macrophage colony stimulating factor.
    Bunin N; Leahey A; Kamani N; August C
    J Pediatr Hematol Oncol; 1996 Feb; 18(1):68-71. PubMed ID: 8556374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party.
    Bacigalupo A; Broccia G; Corda G; Arcese W; Carotenuto M; Gallamini A; Locatelli F; Mori PG; Saracco P; Todeschini G
    Blood; 1995 Mar; 85(5):1348-53. PubMed ID: 7532040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midolio Osseo (GITMO).
    Bacigalupo A; Bruno B; Saracco P; Di Bona E; Locasciulli A; Locatelli F; Gabbas A; Dufour C; Arcese W; Testi G; Broccia G; Carotenuto M; Coser P; Barbui T; Leoni P; Ferster A
    Blood; 2000 Mar; 95(6):1931-4. PubMed ID: 10706857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocyte-macrophage colony-stimulating factor in the sera of patients with aplastic anemia.
    Schrezenmeier H; Raghavachar A; Heimpel H
    Clin Investig; 1993 Feb; 71(2):102-8. PubMed ID: 8461622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Time course changes in the count of peripheral granulocytes in children with acquired aplastic anemias treated with antithymocyte globulin, cyclosporin A and granulocytic colony stimulating factor].
    Bogacheva NIu; Novichkova GA; Litvinov DV; Khachatrian LA; Baĭdil'dina DD; Shneĭder MM; Suntsova EV; Skorobogatova EV; Maschan AA
    Ter Arkh; 2002; 74(12):71-7. PubMed ID: 12577848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of severe aplastic anemia with an immunosuppressive agent plus recombinant human granulocyte-macrophage colony-stimulating factor and erythropoietin.
    Shao Z; Chu Y; Zhang Y; Chen G; Zheng Y
    Am J Hematol; 1998 Nov; 59(3):185-91. PubMed ID: 9798655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia.
    Kojima S; Hibi S; Kosaka Y; Yamamoto M; Tsuchida M; Mugishima H; Sugita K; Yabe H; Ohara A; Tsukimoto I
    Blood; 2000 Sep; 96(6):2049-54. PubMed ID: 10979946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunosuppressive therapy for 54 children patients with acquired severe aplastic anemia].
    Chen C; Fang JP; Huang SL; Zhong FY
    Zhonghua Er Ke Za Zhi; 2006 Nov; 44(11):841-4. PubMed ID: 17274875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte colony-stimulating factor-supported combined immunosuppressive therapy (antilymphocyte globulin, cyclosporine, and methylprednisolone) in patients with aplastic anemia: tolerability, efficacy, and changes in the progenitor cell compartment.
    Meidlinger P; Knöbl P; Jäger U; Gisslinger H; Pabinger I; Weltermann A; Lechner K; Geissler K
    Ann Hematol; 1999 Jul; 78(7):299-304. PubMed ID: 10466441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Very low doses of GM-CSF administered alone or with erythropoietin in aplastic anemia.
    Kurzrock R; Talpaz M; Gutterman JU
    Am J Med; 1992 Jul; 93(1):41-8. PubMed ID: 1626572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of children with aplastic anemia treated with immunosuppressive therapy.
    Pongtanakul B; Das PK; Charpentier K; Dror Y
    Pediatr Blood Cancer; 2008 Jan; 50(1):52-7. PubMed ID: 17941069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome.
    Rosenfeld S; Follmann D; Nunez O; Young NS
    JAMA; 2003 Mar; 289(9):1130-5. PubMed ID: 12622583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot study using tacrolimus rather than cyclosporine plus antithymocyte globulin as an immunosuppressive therapy regimen option for severe aplastic anemia in adults.
    Zhu X; Guan J; Xu J; Wei J; Jiang L; Yin J; Zhao L; Zhang Y
    Blood Cells Mol Dis; 2014 Sep; 53(3):157-60. PubMed ID: 24931461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rabbit antithymocyte globulin (r-ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapy. Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
    Di Bona E; Rodeghiero F; Bruno B; Gabbas A; Foa P; Locasciulli A; Rosanelli C; Camba L; Saracco P; Lippi A; Iori AP; Porta F; De Rossi G; Comotti B; Iacopino P; Dufour C; Bacigalupo A
    Br J Haematol; 1999 Nov; 107(2):330-4. PubMed ID: 10583220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collection of peripheral blood hematopoietic progenitors (PBHP) from patients with severe aplastic anemia (SAA) after prolonged administration of granulocyte colony-stimulating factor.
    Bacigalupo A; Piaggio G; Podestá M; Van Lint MT; Valbonesi M; Lercari G; Mori PG; Pasino M; Franchini E; Rivabella L
    Blood; 1993 Sep; 82(5):1410-4. PubMed ID: 7689868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of aplastic anemia with antithymocyte globulin, cyclosporin A, methylprednisolone, danazol and recombinant human granulocyte-colony stimulating factor.
    Shichino H; Mugishima H; Takamura M; Shimada T; Suzuki T; Chin M; Harada K; Ryo S; Kojima S
    Acta Paediatr Jpn; 1996 Dec; 38(6):644-7. PubMed ID: 9002302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.